Global Contract Research Organization (CRO) Services Market Rise At a Robust 8% CAGR by 2026

Growing R&D investment, increased innovation in therapeutic areas such as cancer and rare illnesses, the need for cost-efficiency and faster time-to-market, rigorous regulations, and the increasing complexity of pharmaceuticals and clinical trials are driving the worldwide Contract Research Organization (CRO) services market.

(firmenpresse) - The level of outsourcing to CROs varies by function and is largest in the laboratory testing, clinical trial, and post-approval stages when compared to the discovery and pre-clinical stages. The ratio of outsourcing is proportional to the complexity and regulatory expertise necessary at each level. The pharmaceutical, biotechnology, and medical device industries typically outsource to CROs for the following reasons:

• Positive return on R&D investments

• Lack of internal capabilities (esp. small biopharma companies)

• Growing complexity in developing targeted therapeutic areas like immuno-oncology therapies

• Stringent regulatory requirements

• Time and cost-efficiency

Impact of Covid-19: Growing Interest in Virtual Clinical Trials

CROs are proactively shifting site operations to decentralized/virtual trials wherever practicable to protect the integrity and regulatory compliance of current studies.

“COVID-19 has necessitated the rapid uptake of a decentralized clinical trial approach to monitoring clinical trials. There was a brief period where, with the pandemic happening, most companies were faced with a huge stop in their clinical trial activities, which required rethinking, retooling, and re-strategizing how best to re-engage these sites with the clinical trials that they have currently ongoing.” - Former Division Leader, Industry-Leading CRO, US

Full-Service CROs/One-Stop Shops are becoming more popular in the market.

Due to the complexities of drug development, biopharma companies require a full-service CRO solution throughout the drug development lifecycle. CROs are progressively providing scalable services, specialized technology, and a global presence in addition to the variety of services (pre-clinical, clinical, and commercialization).

Get Comprehensive Market Insights on CRO Services Market @ https://www.globenewswire.com/en/news-release/2022/05/10/2439889/0/en/Global-Contract-Research-Organization-CRO-Services-Market-valued-a-75-billion-in-2021-is-anticipated-to-witness-a-CAGR-of-8-to-reach-110-billion-by-2026.html



Increasing Therapeutic and Clinical Trial Complexity

Clinical trials and specific therapeutic areas (such as cancer, CNS, cardiovascular, and diabetes) are becoming increasingly complicated, making them more expensive and harder to create in-house, according to the CRO industry. Furthermore, the shifting regulatory environment and onerous penalties for noncompliance lengthen, expense, and complexity of drug development, making it more appealing to outsource.

Competitive Landscape Analysis: Contract Research Organization (CRO) Services market

Over the previous decade, the CRO business has seen tremendous consolidation, transitioning from a highly fragmented market to a more consolidated environment. This trend is mostly driven by big pharma's desire to work with fewer full-service CROs. IQVIA, Labcorp, Syneos Health, Thermo Fisher Scientific, Parexel, ICON, Charles River, WUXI Apptec, Pharmacon Beijing, and SGS are some of the prominent companies in the Contract Research Organization (CRO) services industry.

Explore Detailed Insights on CRO Services Market @ https://meditechinsights.com/contract-research-organization-cro-services-market/Weitere Infos zu dieser Pressemeldung:
Unternehmensinformation / Kurzprofil:
PresseKontakt / Agentur:
Bereitgestellt von Benutzer: Prathamesh
Datum: 18.10.2023 - 11:29 Uhr
Sprache: Deutsch
News-ID 2068158
Anzahl Zeichen: 3800

Kontakt-Informationen:
Ansprechpartner: Prathamesh Medi Tech
Stadt:

Brussels

Telefon: 0498868079

Kategorie:

Gesundheitswesen - Medizin

Meldungsart: Finanzinformation
Versandart: Veröffentlichung
Freigabedatum: 18.10.2023

Diese Pressemitteilung wurde bisher 399 mal aufgerufen.

Growing Focus on Augmented Reality Spurs 13% CAGR in Global Bionic Contact Lense ...

Bionic contact lenses are an innovative blend of traditional contact lenses and advanced tech, promising to reshape vision correction and AR experiences by overlaying digital information in real time. They offer benefits such as addressing nearsighte ...

The Bioburden Testing Market Continues Upward Trend with a Projected 12-15% CAGR ...

Bioburden testing, an essential quality control process in pharmaceutical and medical device production, evaluates microbial contamination levels on products, raw materials, and manufacturing settings, including bacteria, fungi, yeasts, and molds. Th ...

The Cardiac Resuscitation Devices Market is Poised to achieve a CAGR of 6-7% by ...

Cardiopulmonary resuscitation (CPR), another name for cardiac resuscitation, is an emergency treatment given to people who are experiencing cardiac arrest—a condition in which the heart stops beating efficiently—in an emergency. In order to susta ...

Alle Meldungen von Medi-tech insights